Global Medical Technologies Inc (GLOB1)

Sector:
INFORMATION TECHNOLOGY
Industry:
SOFTWARE
SIC:
SERVICES-MANAGEMENT SERVICES
CEO:
Martín Migoya
Employees:
5,631
37A AVENUE J.F. KENNEDY, N/A, LUXEMBOURG L-1855
35 220301596

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Globant SA operates as an technology services provider, which focuses on delivering software solutions that leverage emerging technologies and related market trends. It also provides services related to application development, testing, infrastructure management and application maintenance. The company was founded by Martín Migoya, Martín Gonzalo Umaran, Guibert Andrés Englebienne and Néstor Nocetti in 2003 and is headquartered in Luxembourg.

Data derived from most recent annual or quarterly report
Market Cap 1.463 Billion Shares Outstanding36.343 Million Avg 30-day Volume 50.739 Thousand
P/E Ratio33.4385 Dividend Yield0.0 EPS
Price to Revenue9.2838 Debt to Equity0.0 EBITDA275.495 Million
Price to Book Value168.6909 Operating Margin31.646400000000003 Enterprise Value7.772 Billion
Current Ratio2.925 EPS Growth-0.042 Quick Ratio2.916
1 Yr BETA -1.8282 52-week High/Low 0.0 / Profit Margin6.2343
Operating Cash Flow Growth0.0 Altman Z-Score13.5213 Free Cash Flow to Firm 1.015 Billion
View SEC Filings from GLOB1 instead.

View recent insider trading info

Funds Holding GLOB1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GLOB1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARCINEK THOMAS F PRESIDENT AND COO

  • Officer
0 2010-04-12 0

HUNT T KENDALL

  • Director
0 2010-04-12 0

RUXIN MICHAEL I CHAIRMAN OF THE BOARD AND CEO

  • Officer
0 2010-04-12 0

GEIST KIM SECRETARY

  • Officer
0 2010-04-12 0

WILLMAN GERALD F JR SR VP SALES MARKETING EUROPE

  • Officer
0 2010-04-12 0

CRAIG DARREN P ACTING CHIEF FINANCIAL OFFICER

  • Officer
0 2010-04-12 0

PELLEGRINI TIMOTHY J SR VP AND GENERAL MANAGER

  • Officer
0 2010-04-12 0

DUSTIN WILLIAM SCOTT SR VP OF MARKETING AMERICA

  • Officer
0 2010-04-12 0

CSORE MIKLOS SR VP OF RESEARCH&DEVELOPMENT

  • Officer
0 2010-04-12 0

HAEMONETICS CORP

ATLAS ACQUISITION CORP.

  • 10% Owner
31,428,730 2010-03-25 0

GILMORE ROBERT R

  • FORMER DIRECTOR
0 2010-03-25 0

EAMES SARAH L

  • FORMER DIRECTOR
0 2010-03-25 0

LOPEZ ALICIA R

  • Director
0 2010-03-25 0

CONCANNON BRIAN

  • Director
0 2010-03-25 0

LINDOP CHRISTOPHER J

  • Director
0 2010-03-25 0

VICTORY PARK SPECIAL SITUATIONS MASTER FUND, LTD.

JACOB CAPITAL, L.L.C.

VICTORY PARK CAPITAL ADVISORS, LLC

LEVY RICHARD N

  • 10% Owner
No longer subject to file 2010-03-25 0

DAVIS KAREN BERRIMAN CHIEF FINANCIAL OFFICER

  • Officer
0 2008-11-17 0

FUTURISTIC IMAGE BUILDER LTD

  • 10% Owner
No longer subject to file 2008-03-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments